At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FFTY Innovator IBD 50 ETF
Pre-Mkt 06-05 04:50:51 EDT
42.29
+0.48
+1.15%
High42.65Low40.48Vol42.57K
Open40.72D1 Closing41.81Amplitude5.19%
Mkt Cap97.27MTradable Cap97.27MTotal Shares2.30M
T/O1.77MT/O Rate1.85%Tradable Shares2.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

24H | Chip, Storage, Optical Stocks Fall with AMD, Micron, Intel, Down 2%; Lumentum Down 3%; Marvell, AAOI Down 4%. Lululemon Tumbles 11%, ServiceTitan Gains 15%
US Overnight  ·  08:12
24H | Chip, Storage, Optical Stocks Fall with AMD, Micron, Intel, Down 2%; Lumentum Down 3%; Marvell, AAOI Down 4%. Lululemon Tumbles 11%, ServiceTitan Gains 15%
Fabrinet (FN) Deepens Co-Packaged Optics Ties With Raytek Semiconductor Is Its Edge Strengthening?
Simply Wall St.  ·  01:17
Fabrinet (FN) Deepens Co-Packaged Optics Ties With Raytek Semiconductor Is Its Edge Strengthening?
Travere Therapeutics says Filspari generally well tolerated in Phase 3 study
TIPRANKS  ·  06-04 22:15
Travere Therapeutics says Filspari generally well tolerated in Phase 3 study
24H | Broadcom Tumbles 13%; CrowdStrike Slides 10%; Navitas, SOXL Drop over 6%; SMCI, Marvell Fall Around 5%; Micron, AMD Fall Around 3%; Cisco Climbs 3%
US Overnight  ·  06-04 08:11
24H | Broadcom Tumbles 13%; CrowdStrike Slides 10%; Navitas, SOXL Drop over 6%; SMCI, Marvell Fall Around 5%; Micron, AMD Fall Around 3%; Cisco Climbs 3%
Travere Therapeutics price target raised to $62 from $59 at Citi
TIPRANKS  ·  06-04 01:05
Travere Therapeutics price target raised to $62 from $59 at Citi
Analyst Reiterates Buy on Travere as Civorebrutinib Deal Expands Renal Franchise; $56 Price Target Maintained
TIPRANKS  ·  06-03 21:38
Analyst Reiterates Buy on Travere as Civorebrutinib Deal Expands Renal Franchise; $56 Price Target Maintained
Travere Therapeutics Price Target Maintained With a $55.00/Share by Wedbush
Dow Jones  ·  06-03 20:50
Travere Therapeutics Price Target Maintained With a $55.00/Share by Wedbush
Why the Memory Chip Shortage Persists: Morgan Stanley Cites Cleanroom and Lithography Constraints
Deep News  ·  06-03 20:39
Why the Memory Chip Shortage Persists: Morgan Stanley Cites Cleanroom and Lithography Constraints
Vertiv Keeps Quarterly Dividend at $0.0625 a Share, Payable June 25 to Shareholders of Record on June 15
MT Newswires Live  ·  06-03 20:04
Vertiv Keeps Quarterly Dividend at $0.0625 a Share, Payable June 25 to Shareholders of Record on June 15
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), AbSci (ABSI) and Travere Therapeutics (TVTX)
TIPRANKS  ·  06-03 20:01
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), AbSci (ABSI) and Travere Therapeutics (TVTX)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Picard Medical, Inc. (PMI) and Travere Therapeutics (TVTX)
TIPRANKS  ·  06-03 19:50
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Picard Medical, Inc. (PMI) and Travere Therapeutics (TVTX)
Vertiv Declares Quarterly Cash Dividend on Class A Shares
TIPRANKS  ·  06-03 19:16
Vertiv Declares Quarterly Cash Dividend on Class A Shares
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Gilead Sciences (GILD) and Celcuity (CELC)
TIPRANKS  ·  06-03 17:31
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Gilead Sciences (GILD) and Celcuity (CELC)
Credo Technology Surges on Record Earnings and Optics Plan
TIPRANKS  ·  06-03 08:16
Credo Technology Surges on Record Earnings and Optics Plan
3 Overlooked ‘Strong Buy’ Data Center Stocks, 6/2/26
TIPRANKS  ·  06-03 03:25
3 Overlooked ‘Strong Buy’ Data Center Stocks, 6/2/26
Travere Therapeutics price target raised to $67 from $57 at H.C. Wainwright
TIPRANKS  ·  06-03 00:32
Travere Therapeutics price target raised to $67 from $57 at H.C. Wainwright
Sterling Infrastructure Is Maintained at Overweight by Keybanc
Dow Jones  ·  06-02 22:44
Sterling Infrastructure Is Maintained at Overweight by Keybanc
Travere Therapeutics enters into exclusive licensing agreement with Everest
TIPRANKS  ·  06-02 19:57
Travere Therapeutics enters into exclusive licensing agreement with Everest
Travere Therapeutics Signs Deal to License Potential Kidney Disease Drug From Everest Medicines
MT Newswires Live  ·  06-02 19:45
Travere Therapeutics Signs Deal to License Potential Kidney Disease Drug From Everest Medicines
Travere Licenses Civorebrutinib, Expands Kidney Disease Pipeline
TIPRANKS  ·  06-02 19:40
Travere Licenses Civorebrutinib, Expands Kidney Disease Pipeline
No data available

Introduction

Company Name.
Innovator IBD 50 ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.
Issue price:
--